← Back
$ALNY All transactions

ALNYLAM PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

775

Price

$0

Filed

May 12

Insider

Name

Sigal Charles Elliott

Title

CIK

0001661908

Roles

Director

Transaction Details

Transaction Date

2025-05-08

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

775

Footnotes

These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date. | Shares held by Sigal Family Investments, LLC, of which the reporting person is Managing Member. | The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Filing Info

Accession No.

0001735276-25-000060

Form Type

4

Issuer CIK

0001178670

Sigal Charles Elliott's History

Date Ticker Type Value
2025-05-30 VIR A $0
2025-05-30 VIR A $0
2025-05-08 ALNY A $0
2025-05-08 ALNY A $0

Other Insiders at ALNY (90d)

Insider Bought Sold Last
Greenstreet Yvonne
Chief Executive Officer
$5.3M 2026-03-04
SUPRAN BRYAN
EVP, CLO and Secretary
2026-03-02
Poulton Jeffrey V.
EVP, Chief Financial Officer
$2.2M 2026-03-04
Garg Pushkal
EVP Chief R&D
$4.9M 2026-03-05
Tanguler Tolga
EVP, Chief Commercial Officer
$1.9M 2026-03-04
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
$2.8M 2026-03-05
McLaughlin Melissa
Chief Human Resources Officer
$1.3M 2026-04-06